Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
Br J Ophthalmol
    May 2024
  1. ZHONG P, Yang S, Liu R, Zhu Z, et al
    Handgrip strength and risks of diabetic vascular complications: Evidence from Guangzhou Diabetic Eye Study and UK cohorts.
    Br J Ophthalmol. 2024 May 30:bjo-2023-324893. doi: 10.1136/bjo-2023-324893.
    >> Share

  2. BRESSLER I, Aviv R, Margalit D, Rom Y, et al
    Autonomous screening for laser photocoagulation in fundus images using deep learning.
    Br J Ophthalmol. 2024;108:742-746.
    >> Share

  3. JIN G, Ma Y, Zheng D, Jin L, et al
    Evaluation of systemic medications associated with diabetic retinopathy: a nested case-control study from the UK Biobank.
    Br J Ophthalmol. 2024 May 20:bjo-2023-324930. doi: 10.1136/bjo-2023-324930.
    >> Share

  4. CHEONG KX, Zhang C, Tan TE, Fenner BJ, et al
    Comparing generative and retrieval-based chatbots in answering patient questions regarding age-related macular degeneration and diabetic retinopathy.
    Br J Ophthalmol. 2024 May 15:bjo-2023-324533. doi: 10.1136/bjo-2023-324533.
    >> Share

  5. VINGOPOULOS F, Baldwin G, Katz R, Cui Y, et al
    Associations of quantitative contrast sensitivity with vascular metrics on widefield swept-source OCT angiography across stages of diabetic retinopathy.
    Br J Ophthalmol. 2024 May 6:bjo-2023-323900. doi: 10.1136/bjo-2023-323900.
    >> Share

    February 2024
  6. GU C, Wang Y, Jiang Y, Xu F, et al
    Application of artificial intelligence system for screening multiple fundus diseases in Chinese primary healthcare settings: a real-world, multicentre and cross-sectional study of 4795 cases.
    Br J Ophthalmol. 2024;108:424-431.
    >> Share

  7. CASSWELL EJ, Cro S, Cornelius VR, Banerjee PJ, et al
    Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: The ASCOT study.
    Br J Ophthalmol. 2024;108:440-448.
    >> Share

  8. DURRANI AF, Momenaei B, Wakabayashi T, Vemula S, et al
    Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.
    Br J Ophthalmol. 2024 Feb 12:bjo-2023-324394. doi: 10.1136/bjo-2023-324394.
    >> Share

  9. MELLOR J, Jiang W, Fleming A, McGurnaghan SJ, et al
    Prediction of retinopathy progression using deep learning on retinal images within the Scottish screening programme.
    Br J Ophthalmol. 2024 Feb 5:bjo-2023-323400. doi: 10.1136/bjo-2023-323400.
    >> Share

    October 2023
  10. DESAI P, De Silva SR
    Diabetic retinopathy screening: does one size fit all?
    Br J Ophthalmol. 2023 Oct 24:bjo-2023-324448. doi: 10.1136/bjo-2023-324448.
    >> Share

  11. OLVERA-BARRIOS A, Rudnicka AR, Anderson J, Bolter L, et al
    Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effect.
    Br J Ophthalmol. 2023 Oct 24:bjo-2023-324097. doi: 10.1136/bjo-2023-324097.
    >> Share

  12. TAN R, Teo KYC, Husain R, Tan NC, et al
    Evaluating the outcome of screening for glaucoma using colour fundus photography-based referral criteria in a teleophthalmology screening programme for diabetic retinopathy.
    Br J Ophthalmol. 2023 Oct 18:bjo-2023-323339. doi: 10.1136/bjo-2023-323339.
    >> Share

  13. FINN M, Baldwin G, Garg I, Wescott HE, et al
    Comparative study of widefield swept-source optical coherence tomography angiography in eyes with concomitant age-related macular degeneration and diabetic retinopathy.
    Br J Ophthalmol. 2023 Oct 16:bjo-2023-323792. doi: 10.1136/bjo-2023-323792.
    >> Share

    September 2023
  14. FLEMING AD, Mellor J, McGurnaghan SJ, Blackbourn LAK, et al
    Deep learning detection of diabetic retinopathy in Scotland's diabetic eye screening programme.
    Br J Ophthalmol. 2023 Sep 13:bjo-2023-323395. doi: 10.1136/bjo-2023-323395.
    >> Share

    August 2023
  15. WHITESTONE N, Nkurikiye J, Patnaik JL, Jaccard N, et al
    Feasibility and acceptance of artificial intelligence-based diabetic retinopathy screening in Rwanda.
    Br J Ophthalmol. 2023 Aug 4:bjo-2022-322683. doi: 10.1136/bjo-2022-322683.
    >> Share

    June 2023
  16. GIANNAKIS P, Nderitu P, Nunez do Rio JM, Webster L, et al
    Effect of socioeconomic deprivation as determined by the English deprivation deciles on the progression of diabetic retinopathy and maculopathy: a multivariate case-control analysis of 88 910 patients attending a South-East London diabetic eye screeni
    Br J Ophthalmol. 2023 Jun 28:bjo-2023-323402. doi: 10.1136/bjo-2023-323402.
    >> Share

  17. ZHANG Y, Huang W, Tian Q, Bai G, et al
    Network pharmacology and biochemical experiments reveal the antiapoptotic mechanism of huperzine A for treating diabetic retinopathy.
    Br J Ophthalmol. 2023 Jun 20:bjo-2023-323639. doi: 10.1136/bjo-2023-323639.
    >> Share

    April 2023
  18. SALONGCAY RP, Jacoba CMP, Salva CMG, Rageh A, et al
    One-field, two-field and five-field handheld retinal imaging compared with standard seven-field Early Treatment Diabetic Retinopathy Study photography for diabetic retinopathy screening.
    Br J Ophthalmol. 2023 Apr 24:bjophthalmol-2022-321849.
    >> Share

    February 2023
  19. CHIA MA, Hersch F, Sayres R, Bavishi P, et al
    Validation of a deep learning system for the detection of diabetic retinopathy in Indigenous Australians.
    Br J Ophthalmol. 2023 Feb 6:bjo-2022-322237. doi: 10.1136/bjo-2022-322237.
    >> Share

  20. STERLING J, Hua P, Dunaief JL, Cui QN, et al
    Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma.
    Br J Ophthalmol. 2023;107:215-220.
    >> Share

    January 2023
  21. PANDEY PU, Ballios BG, Christakis PG, Kaplan AJ, et al
    An ensemble of deep convolutional neural networks is more accurate and reliable than board-certified ophthalmologists at detecting multiple diseases in retinal fundus photographs.
    Br J Ophthalmol. 2023 Jan 31:bjo-2022-322183. doi: 10.1136/bjo-2022-322183.
    >> Share

  22. ASHRAF M, AbdelAl O, Shokrollahi S, Pitoc CM, et al
    Evaluation of diabetic retinopathy severity on ultrawide field colour images compared with ultrawide fluorescein angiograms.
    Br J Ophthalmol. 2023 Jan 20:bjo-2022-322163. doi: 10.1136/bjo-2022-322163.
    >> Share

  23. XIONG H, You QS, Guo Y, Wang J, et al
    Deep learning-based signal-independent assessment of macular avascular area on 6x6 mm optical coherence tomography angiogram in diabetic retinopathy: a comparison to instrument-embedded software.
    Br J Ophthalmol. 2023;107:84-89.
    >> Share

  24. FRASER-BELL S, Kang HK, Mitchell P, Arnold JJ, et al
    Dexamethasone intravitreal implant in treatment-naive diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study.
    Br J Ophthalmol. 2023;107:72-78.
    >> Share

  25. CORNISH EE, Teo KY, Gillies MC, Lim LL, et al
    Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.
    Br J Ophthalmol. 2023;107:79-83.
    >> Share

    November 2022
  26. HUI Z, Guo X, Bulloch G, Yuan M, et al
    Rates of choroidal loss and ganglion cell-inner plexiform layer thinning in type 2 diabetes mellitus and healthy individuals: a 2-year prospective study.
    Br J Ophthalmol. 2022 Nov 16. pii: bjo-2022-321603. doi: 10.1136/bjo-2022-321603
    >> Share

  27. STINO H, Niederleithner M, Iby J, Sedova A, et al
    Detection of diabetic neovascularisation using single-capture 65 degrees -widefield optical coherence tomography angiography.
    Br J Ophthalmol. 2022 Nov 14. pii: bjo-2022-322134. doi: 10.1136/bjo-2022-322134
    >> Share

  28. MAREDZA M, Mistry H, Lois N, Aldington S, et al
    Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study.
    Br J Ophthalmol. 2022;106:1549-1554.
    >> Share

    October 2022
  29. LEE PK, Ra H, Baek J
    Automated segmentation of ultra-widefield fluorescein angiography of diabetic retinopathy using deep learning.
    Br J Ophthalmol. 2022 Oct 14. pii: bjo-2022-321063. doi: 10.1136/bjo-2022-321063
    >> Share

  30. OLVERA-BARRIOS A, Mishra AV, Schwartz R, Khatun M, et al
    Formal registration of visual impairment in people with diabetic retinopathy significantly underestimates the scale of the problem: a retrospective cohort study at a tertiary care eye hospital service in the UK.
    Br J Ophthalmol. 2022 Oct 14. pii: bjo-2022-321910. doi: 10.1136/bjo-2022-321910
    >> Share

  31. ABRAHAM JR, Wykoff CC, Arepalli S, Lunasco L, et al
    Exploring the angiographic-biologic phenotype in the IMAGINE study: quantitative UWFA and cytokine expression.
    Br J Ophthalmol. 2022;106:1444-1449.
    >> Share

  32. LIU K, Wang H, He W, Ye J, et al
    Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.
    Br J Ophthalmol. 2022;106:1436-1443.
    >> Share

  33. GAD H, Al-Jarrah B, Saraswathi S, Mohamed S, et al
    Corneal confocal microscopy identifies a reduction in corneal keratocyte density and sub-basal nerves in children with type 1 diabetes mellitus.
    Br J Ophthalmol. 2022;106:1368-1372.
    >> Share

    September 2022
  34. GAO Z, Pan X, Shao J, Jiang X, et al
    Automatic interpretation and clinical evaluation for fundus fluorescein angiography images of diabetic retinopathy patients by deep learning.
    Br J Ophthalmol. 2022 Sep 28. pii: bjo-2022-321472. doi: 10.1136/bjo-2022-321472
    >> Share

  35. VIGGIANO P, Costanzo E, Giannini D, Fragiotta S, et al
    In vivo assessment of associations between photoreceptors structure and macular perfusion in type 1 diabetes.
    Br J Ophthalmol. 2022 Sep 1. pii: bjo-2022-321617. doi: 10.1136/bjo-2022-321617.
    >> Share

    August 2022
  36. BIKBOV MM, Zainullin RM, Gilmanshin TR, Iakupova EM, et al
    Hand grip strength and ocular associations: the Ural Eye and Medical Study.
    Br J Ophthalmol. 2022 Aug 11. pii: bjo-2022-321404. doi: 10.1136/bjo-2022-321404
    >> Share

  37. LI B, Chen H, Zhang B, Yuan M, et al
    Development and evaluation of a deep learning model for the detection of multiple fundus diseases based on colour fundus photography.
    Br J Ophthalmol. 2022;106:1079-1086.
    >> Share

    July 2022
  38. LIN Z, Wen L, Wang Y, Li D, et al
    Incidence, progression and regression of diabetic retinopathy in a northeastern Chinese population.
    Br J Ophthalmol. 2022 Jul 19. pii: bjo-2022-321384. doi: 10.1136/bjo-2022-321384
    >> Share

  39. KHORAMNIA R, Peto T, Koch F, Taylor SR, et al
    Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study.
    Br J Ophthalmol. 2022 Jul 15. pii: bjo-2022-321415. doi: 10.1136/bjo-2022-321415
    >> Share

  40. LIU Y, Yao B, Chen X, Yang X, et al
    Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study.
    Br J Ophthalmol. 2022 Jul 15. pii: bjo-2021-320754. doi: 10.1136/bjo-2021-320754
    >> Share

    June 2022
  41. ZHUANG X, Chen R, Liang A, Yao J, et al
    Multimodal imaging analysis for the impact of retinal peripheral lesions on central neurovascular structure and retinal function in type 2 diabetes with diabetic retinopathy.
    Br J Ophthalmol. 2022 Jun 30. pii: bjo-2022-321297. doi: 10.1136/bjo-2022-321297
    >> Share

    May 2022
  42. WANG W, Cheng W, Yang S, Chen Y, et al
    Choriocapillaris flow deficit and the risk of referable diabetic retinopathy: a longitudinal SS-OCTA study.
    Br J Ophthalmol. 2022 May 16. pii: bjophthalmol-2021-320704.
    >> Share

  43. SANTOS T, Warren LH, Santos AR, Marques IP, et al
    Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR.
    Br J Ophthalmol. 2022;106:712-718.
    >> Share

    April 2022
  44. YANG DW, Tang ZQ, Tang FY, Szeto SK, et al
    Clinically relevant factors associated with a binary outcome of diabetic macular ischaemia: an OCTA study.
    Br J Ophthalmol. 2022 Apr 21. pii: bjophthalmol-2021-320779.
    >> Share

  45. LIN CC, Lee CY, Huang JY, Hsu SM, et al
    Trends in diabetic eye disorders and associated comorbidities in Taiwan: a 10-year nationwide population-based cohort study.
    Br J Ophthalmol. 2022 Apr 8. pii: bjophthalmol-2021-320917.
    >> Share

    March 2022
  46. KOLLI A, Sekimitsu S, Wang J, Segre A, et al
    Background polygenic risk modulates the association between glaucoma and cardiopulmonary diseases and measures: an analysis from the UK Biobank.
    Br J Ophthalmol. 2022 Mar 31. pii: bjophthalmol-2021-320305.
    >> Share

    February 2022
  47. PAN Q, Gao Z, Hu X, Wu Q, et al
    Risk factors for epiretinal membrane in eyes with primary rhegmatogenous retinal detachment that received silicone oil tamponade.
    Br J Ophthalmol. 2022 Feb 19. pii: bjophthalmol-2021-320121.
    >> Share

  48. TAN B, Lim NA, Tan R, Gan ATL, et al
    Combining retinal and choroidal microvascular metrics improves discriminative power for diabetic retinopathy.
    Br J Ophthalmol. 2022 Feb 9. pii: bjophthalmol-2021-319739.
    >> Share

  49. WANG W, Chen Y, Xiong K, Gong X, et al
    Longitudinal associations of ocular biometric parameters with onset and progression of diabetic retinopathy in Chinese adults with type 2 diabetes mellitus.
    Br J Ophthalmol. 2022 Feb 3. pii: bjophthalmol-2021-320046.
    >> Share

  50. WANG W, Guo X, Chen Y, Xiong K, et al
    Choriocapillaris perfusion assessed using swept source optical coherence tomographic angiography and the severity of diabetic retinopathy.
    Br J Ophthalmol. 2022 Feb 3. pii: bjophthalmol-2021-320163.
    >> Share

  51. GOKHALE KM, Adderley NJ, Subramanian A, Lee WH, et al
    Metformin and risk of age-related macular degeneration in individuals with type 2 diabetes: a retrospective cohort study.
    Br J Ophthalmol. 2022 Feb 3. pii: bjophthalmol-2021-319641.
    >> Share

  52. NUSINOVICI S, Zhang L, Chai X, Zhou L, et al
    Machine learning to determine relative contribution of modifiable and non-modifiable risk factors of major eye diseases.
    Br J Ophthalmol. 2022;106:267-274.
    >> Share

    December 2021
  53. ZAFAR S, Staggers KA, Gao J, Liu Y, et al
    Evaluation of retinal nerve fibre layer thickness as a possible measure of diabetic retinal neurodegeneration in the EPIC-Norfolk Eye Study.
    Br J Ophthalmol. 2021 Dec 24. pii: bjophthalmol-2021-319853.
    >> Share

  54. VARGAS-PEIRANO M, Verdejo C, Vergara-Merino L, Loezar C, et al
    Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendations.
    Br J Ophthalmol. 2021 Dec 14. pii: bjophthalmol-2021-319504.
    >> Share

  55. HURU J, Leiviska I, Saarela V, Liinamaa MJ, et al
    Prediabetes influences the structure of the macula: thinning of the macula in the Northern Finland Birth Cohort.
    Br J Ophthalmol. 2021;105:1731-1737.
    >> Share

    November 2021
  56. LIAO M, Huang Y, Wang J, Meng X, et al
    Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy.
    Br J Ophthalmol. 2021 Nov 29. pii: bjophthalmol-2021-320332.
    >> Share

  57. HUGHES R, Aristodemou P, Sparrow JM, Kaye S, et al
    Surgeon effects on cataract refractive outcomes are minimal compared with patient comorbidity and gender: an analysis of 490 987 cases.
    Br J Ophthalmol. 2021 Nov 11. pii: bjophthalmol-2021-320231.
    >> Share

  58. SZETO SK, Hui VWK, Tang FY, Yang D, et al
    OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study.
    Br J Ophthalmol. 2021 Nov 8. pii: bjophthalmol-2021-319587.
    >> Share

  59. RICHTER GM, Lee JC, Khan N, Vorperian A, et al
    Ocular and systemic determinants of perifoveal and macular vessel parameters in healthy African Americans.
    Br J Ophthalmol. 2021 Nov 5. pii: bjophthalmol-2021-319675.
    >> Share

  60. FRIZZIERO L, Parrozzani R, Londei D, Pilotto E, et al
    Quantification of vascular and neuronal changes in the peripapillary retinal area secondary to diabetic retinopathy.
    Br J Ophthalmol. 2021;105:1577-1583.
    >> Share

    October 2021
  61. KOH BMQR, Banu R, Nusinovici S, Sabanayagam C, et al
    100 most-cited articles on diabetic retinopathy.
    Br J Ophthalmol. 2021;105:1329-1336.
    >> Share

    September 2021
  62. SCHREUR V, Ng H, Nijpels G, Stefansson E, et al
    Validation of a model for the prediction of retinopathy in persons with type 1 diabetes.
    Br J Ophthalmol. 2021;105:1286-1288.
    >> Share

    August 2021
  63. SIMONSEN JR, Jarvinen A, Hietala K, Harjutsalo V, et al
    Bacterial infections as novel risk factors of severe diabetic retinopathy in individuals with type 1 diabetes.
    Br J Ophthalmol. 2021;105:1104-1110.
    >> Share

  64. BABIUCH A, Wykoff CC, Hach J, Srivastava S, et al
    Longitudinal panretinal microaneurysm dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study.
    Br J Ophthalmol. 2021;105:1111-1115.
    >> Share

  65. TOTH G, Limburg H, Szabo D, Sandor GL, et al
    Rapid assessment of avoidable blindness-based healthcare costs of diabetic retinopathy in Hungary and its projection for the year 2045.
    Br J Ophthalmol. 2021;105:1116-1120.
    >> Share

    June 2021
  66. LEE D, Agron E, Keenan T, Lovato J, et al
    Visual acuity outcomes after cataract surgery in type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study.
    Br J Ophthalmol. 2021 Jun 18. pii: bjophthalmol-2020-317793.
    >> Share

    May 2021
  67. ALSHAIKH RA, Ryan KB, Waeber C
    Sphingosine 1-phosphate, a potential target in neovascular retinal disease.
    Br J Ophthalmol. 2021 May 7. pii: bjophthalmol-2021-319115.
    >> Share

    November 2020
  68. AJAMIL-RODANES S, Testi I, Luis J, Robson AG, et al
    Evaluation of fluocinolone acetonide 0.19 mg intravitreal implant in the management of birdshot retinochoroiditis.
    Br J Ophthalmol. 2020 Nov 26. pii: bjophthalmol-2020-317372.
    >> Share

    October 2020
  69. SEVGI DD, Scott AW, Martin A, Mugnaini C, et al
    Longitudinal assessment of quantitative ultra-widefield ischaemic and vascular parameters in sickle cell retinopathy.
    Br J Ophthalmol. 2020 Oct 31. pii: bjophthalmol-2020-317241.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016